Real-world effectiveness of cariprazine in major depressive disorder and bipolar I disorder in the United States
This real-world effectiveness study of cariprazine treatment for MDD (adjunctive use) or BP-I demonstrated clinically meaningful and sustained improvement in depression symptoms during short- and long-term follow-up.
Authors
- Chandra J. Cohen-Stavi
- Carl D. Marci
- Roger S. McIntyre (ORCID: https://orcid.org/0000-0003-4733-2523)
- Simranpreet Waraich
- Nadia Nabulsi (ORCID: https://orcid.org/0000-0003-0632-6311)
- Mousam Parikh
- Jamie T. Ta
Institutions
- Harvard University (US)
- University of Toronto (CA)
- AbbVie (United States) (US)
- Massachusetts General Hospital (US)
- Office of Multidisciplinary Activities (US)
- AbbVie (Japan)
Publication Details
- Journal
- Journal of Medical Economics
- Published
- 2025-05-30
- DOI
- https://doi.org/10.1080/13696998.2025.2513766
- Citations
- 6
- Primary Topic
- Bipolar Disorder and Treatment
- Type
- article
- Field-Weighted Citation Impact
- 8.83